Use and Opinions of Care Home Medicines Audit Tools
Launched by UNIVERSITY OF CENTRAL LANCASHIRE · Nov 15, 2021
Trial Information
Current as of May 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The prescribing of medicines is the most frequent health intervention in England. The administration or omission of medicines is not without risk and incidents involving medicines occur. The frequency of prescribing medicines increases with age and frailty. People living in care homes (with and without nursing) are generally older and more frail than similar groups in the community. Therefore, care homes and their staff need to be proficient and safe when administering medicines.
However, an under investigated area of prescribed medicines is the views of people living in care homes, health...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Care homes
- • within pre-agreed areas,
- • registered with the regulator (CQC) for the regulated activities of Residential Care (with or without nursing) that have consented to participate.
- * Theses care homes will also be registered for one or more of the following specialisms:
- • dementia,
- • mental health conditions,
- • physical disabilities,
- • sensory impairments,
- • caring for adults under 65 years
- • caring for adults over 65 years.
- • 2. Residents who have capacity and an adequate understanding of written and verbal English to consent and participate of participating care homes.
- • 3. Care home staff, including registered managers who have an adequate understanding of written and verbal English to consent and participate of participating care homes.
- • 4. Visiting health and social care staff who support care homes in the study locality.
- • 5. Commissioner and regulatory staff with oversight of care homes in the study locality.
- • 6. Medicines monitoring tools used by participating
- • care homes,
- • community pharmacies supporting the participating care homes
- • commissioners and regulators with oversight of care homes in the study locality.
- Exclusion Criteria:
- • 1. Care homes registered with the regulator (CQC)
- • outside of the pre-agreed areas.
- • 2. Care homes registered with the regulator (CQC)
- • within the pre-agreed areas for the regulated activities of Residential Care (with or without nursing) that are also registered for the specialism of supporting younger people.
- • 3. Residents of participating care homes judged by staff to lack capacity, an adequate understanding of written and verbal English to consent and participate, too unwell or might find it distressing.
- • 4. Staff in participating care homes who lack an adequate understanding of written and verbal English to consent and participate.
About University Of Central Lancashire
The University of Central Lancashire (UCLan) is a leading higher education institution based in the UK, renowned for its commitment to pioneering research and innovation in various fields, including healthcare. As a clinical trial sponsor, UCLan leverages its extensive academic expertise and state-of-the-art facilities to conduct high-quality research that advances medical knowledge and improves patient outcomes. The university fosters collaboration between researchers, healthcare professionals, and industry partners, ensuring that clinical trials are conducted with rigor and adherence to ethical standards. UCLan is dedicated to enhancing the scientific community's understanding of health-related issues through impactful clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Preston, Lancashire, United Kingdom
Patients applied
Trial Officials
Malcolm W Irons
Principal Investigator
University of Central Lancashire
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials